1. Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer 
Franz Blaes, MD, Markus Klotz, Hanno Huwer, MD, Uwe Straub, MD, Gerhard Kalweit, MD, Klaus Schimrigk, MD, Hans-Joachim Schäfers, MD 
The Annals of Thoracic Surgery 
Volume 69, Issue 1, Pages (January 2000)
DOI: /S (99)

2. Fig 1
Survival of autoantibody-positive and -negative (AnAb and/or ANA) NSCLC patients shown as Kaplan-Meier plot (p = ).
The Annals of Thoracic Surgery  , DOI: ( /S (99) )

3. Fig 2
Immunofluorescence staining of a NSCLC serum on cerebellar tissue. Axonal staining around the Purkinje cells (serum dilution 1:500, magnification ×500).
The Annals of Thoracic Surgery  , DOI: ( /S (99) )

4. Fig 3
Western blot using cerebellar soluble protein fraction as antigens. (Lane S) Standard (Novex Mark 12); (lane 1) anti-Hu-positive NSCLC patient with a typical reactivity at 38 kDa; (lane 2) NSCLC patient with a 45-kDa reactivity and axonal staining, as shown in Figure 1; (lane 3) healthy control patient.
The Annals of Thoracic Surgery  , DOI: ( /S (99) )

5. Fig 4
Survival functions of antineural antibody-positive and -negative NSCLC patients presented as Kaplan-Meier plots. (A) All patients (p = 0.005); (B) stage I and II (p = 0.056); (C) stage III (p = 0.026).
The Annals of Thoracic Surgery  , DOI: ( /S (99) )

6. Fig 5
Survival functions of stage III patients grouped by ANA finding presented as Kaplan-Meier plots. Log-rank test showed a significantly better prognosis of the ANA-positive stage III patients (p = ).
The Annals of Thoracic Surgery  , DOI: ( /S (99) )